Home Current issue Ahead of print Search About us Editorial board Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 353
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2014  |  Volume : 1  |  Issue : 2  |  Page : 67-69

The Association between Vitamin C Prescription and Serum Oxalate Among Hemodialysis Patients


1 Department of Community Health, Golestan University of Medical Sciences, Golestan, Iran
2 Department of Nephrology, Golestan University of Medical Sciences, Golestan, Iran
3 Department of Biochemistery and Nutrition, Golestan University of Medical Sciences, Golestan, Iran
4 Department of Psychiatric Nursing, Qum University of Medical Sciences, Golestan, Iran
5 Department of Clinical Biochemistry, Golestan University of Medical Sciences, Golestan, Iran

Correspondence Address:
Gholamreza Veghari
Ischemic Disorders Research Center, Golestan University of Medical Sciences, Gorgan
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2225-1243.143385

Rights and Permissions

Background and Objective: Vitamin C consumption is necessary to compensate for its deficiency in hemodialysis patients, but excessive use raises concerns about increased levels of serum oxalate and oxalosis. This study was performed to compare the influence of intravenous and oral Vitamin C consumption on serum oxalate among hemodialysis patients in the 5 th Azar Hospital in Golestan (north of Iran). Materials and Methods: In the randomized controlled trial, 75 hemodialysis patients were selected via convenience methods. They were randomly allocated into controls (n = 25), oral Vitamin C (OAA) (n = 25) and intravenous Vitamin C (IAA) groups (n = 25). After the dialysis session (three times weekly), patients took 300 mg intravenous Vitamin C in the IAA group and orally 500 mg Vitamin C in the OAA group for 8 weeks. Serum oxalate was examined before and after therapy. SPSS 16.0 software was used for the statistical analysis. Chi-square and ANOVA were used for comparing groups. A P-value less than 0.05 was considered to be statistically significant. Results: There was no significant difference among the three groups based on mean of serum oxalate before and after intervention. After intervention, the mean value of serum oxalate was not significantly increased in the IAA and OAA groups compared with the control group. A mean difference of serum oxalate before and after IAA was not statistically significant. The mean of serum oxalate before and after intervention significantly increased in the two intervention groups (P < 0.05). Conclusion: In the hemodialysis patients, the procedure of Vitamin C supplementation was associated with the serum oxalate level. Serum oxalate level unchanged in the injected method but it is significantly increased in daily oral Vitamin C supplementation.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1357    
    Printed41    
    Emailed0    
    PDF Downloaded125    
    Comments [Add]    

Recommend this journal